{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:39:20Z","timestamp":1780454360109,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11060-019-03208-w","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T05:08:51Z","timestamp":1560402531000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Prognostic markers for immunodeficiency-associated primary central nervous system lymphoma"],"prefix":"10.1007","volume":"144","author":[{"given":"Leon D.","family":"Kaulen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Galluzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Barbiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Karschnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Huttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fulbright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-6793","authenticated-orcid":false,"given":"Joachim M.","family":"Baehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,13]]},"reference":[{"key":"3208_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/neuonc\/nox158","volume":"19","author":"QT Ostrom","year":"2017","unstructured":"Ostrom QT, Gittleman H, Liao P et al (2017) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010\u20132014. Neuro Oncol 19:1\u201388","journal-title":"Neuro Oncol"},{"issue":"1","key":"3208_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ncpneuro0395","volume":"3","author":"FH Hochberg","year":"2007","unstructured":"Hochberg FH, Baehring JM, Hochberg EP (2007) Primary CNS lymphoma. Nat Clin Pract Neurol 3(1):24\u201335","journal-title":"Nat Clin Pract Neurol"},{"issue":"22","key":"3208_CR3","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1002\/cncr.30965","volume":"123","author":"CH Han","year":"2017","unstructured":"Han CH, Batchelor TT (2017) Diagnosis and management of primary central nervous system lymphoma. Cancer 123(22):4314\u20134324","journal-title":"Cancer"},{"issue":"5","key":"3208_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.blre.2008.03.009","volume":"22","author":"H Tran","year":"2008","unstructured":"Tran H, Nourse J, Hall S, Green M, Griffiths L, Gandhi MK (2008) Immunodeficiency-associated lymphomas. Blood Rev 22(5):261\u2013281","journal-title":"Blood Rev"},{"issue":"8","key":"3208_CR5","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1212\/WNL.0000000000004265","volume":"89","author":"A Moulignier","year":"2017","unstructured":"Moulignier A, Lamirel C, Picard H et al (2017) Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy. Neurology 89(8):796\u2013804","journal-title":"Neurology"},{"issue":"1","key":"3208_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2004-11-4278","volume":"107","author":"WH Navarro","year":"2006","unstructured":"Navarro WH, Kaplan LD (2006) AIDS-related lymphoproliferative disease. Blood 107(1):13\u201320","journal-title":"Blood"},{"issue":"11","key":"3208_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1097\/NEN.0b013e31818beaea","volume":"67","author":"BK Kleinschmidt-DeMasters","year":"2008","unstructured":"Kleinschmidt-DeMasters BK, Damek DM, Lillehei KO, Dogan A, Giannini C (2008) Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications. J Neuropathol Exp Neurol 67(11):1103\u20131111","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"3208_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1215\/15228517-2007-004","volume":"9","author":"BP O\u2019Neill","year":"2007","unstructured":"O\u2019Neill BP, Vernino S, Dogan A, Giannini C (2007) EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil. Neuro-oncology 9(3):364\u2013369","journal-title":"Neuro-oncology"},{"issue":"4","key":"3208_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cncr.24834","volume":"116","author":"R Cavaliere","year":"2010","unstructured":"Cavaliere R, Petroni G, Lopes MB, Schiff D, International Primary Central Nervous System Lymphoma Collaborative G (2010) Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer 116(4):863\u2013870","journal-title":"Cancer"},{"key":"3208_CR10","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/ajt.12211","volume":"13","author":"AM Evens","year":"2013","unstructured":"Evens AM, Choquet S, Kroll-Desrosiers AR et al (2013) Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era. Am J Transpl 13:1512\u20131522","journal-title":"Am J Transpl"},{"issue":"4","key":"3208_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1215\/15228517-2-4-229","volume":"2","author":"TG Phan","year":"2000","unstructured":"Phan TG, O\u2019Neill BP, Kurtin PJ (2000) Posttransplant primary CNS lymphoma. Neuro Oncol 2(4):229\u2013238","journal-title":"Neuro Oncol"},{"issue":"6","key":"3208_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1600-0609.2010.01424.x","volume":"84","author":"H Nagai","year":"2010","unstructured":"Nagai H, Odawara T, Ajisawa A et al (2010) Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era. Eur J Haematol 84(6):499\u2013505","journal-title":"Eur J Haematol"},{"issue":"12","key":"3208_CR13","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1002\/cncr.20300","volume":"100","author":"ME Newell","year":"2004","unstructured":"Newell ME, Hoy JF, Cooper SG et al (2004) Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer 100(12):2627\u20132636","journal-title":"Cancer"},{"issue":"2","key":"3208_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","volume":"4","author":"G Opelz","year":"2004","unstructured":"Opelz G, D\u00f6hler B (2004) Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transpl 4(2):222\u2013230","journal-title":"Am J Transpl"},{"issue":"6","key":"3208_CR15","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1200\/JCO.1993.11.6.1099","volume":"11","author":"JM Pluda","year":"1993","unstructured":"Pluda JM, Venzon DJ, Tosato G et al (1993) Parameters affecting the development of non-Hodgkin\u2019s lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 11(6):1099\u20131107","journal-title":"J Clin Oncol"},{"issue":"6","key":"3208_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/01.TP.0000079253.06061.52","volume":"76","author":"R Snanoudj","year":"2003","unstructured":"Snanoudj R, Durrbach A, Leblond V et al (2003) Primary brain lymphomas after kidney transplantation: presentation and outcome. Transplantation 76(6):930\u2013937","journal-title":"Transplantation"},{"issue":"7","key":"3208_CR17","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3174\/ajnr.A1593","volume":"30","author":"MJ Park","year":"2009","unstructured":"Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY (2009) Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol 30(7):1402\u20131408","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"3208_CR18","doi-asserted-by":"publisher","first-page":"pdb.prot5138","DOI":"10.1101\/pdb.prot5138","volume":"2009","author":"W Tang","year":"2009","unstructured":"Tang W, David FB, Wilson MM et al (2009) DNA extraction from formalin-fixed, paraffin-embedded tissue. Cold Spring Harb Protoc 2009(2):pdb.prot5138","journal-title":"Cold Spring Harb Protoc"},{"issue":"9","key":"3208_CR19","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/jcp.45.9.770","volume":"45","author":"I Ramasamy","year":"1992","unstructured":"Ramasamy I, Brisco M, Morley A (1992) Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms. J Clin Pathol 45(9):770\u2013775","journal-title":"J Clin Pathol"},{"issue":"3","key":"3208_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/cncr.21191","volume":"104","author":"JM Baehring","year":"2005","unstructured":"Baehring JM, Androudi S, Longtine JJ et al (2005) Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer 104(3):591\u2013597","journal-title":"Cancer"},{"issue":"2","key":"3208_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","volume":"21","author":"AJ Ferreri","year":"2003","unstructured":"Ferreri AJ, Blay JY, Reni M et al (2003) Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol 21(2):266\u2013272","journal-title":"J Clin Oncol"},{"issue":"2","key":"3208_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-015-1903-1","volume":"125","author":"DT Ginat","year":"2015","unstructured":"Ginat DT, Purakal A, Pytel P (2015) Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma. J Neurooncol 125(2):297\u2013305","journal-title":"J Neurooncol"},{"issue":"1","key":"3208_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/neuonc\/now155","volume":"19","author":"NK Gupta","year":"2017","unstructured":"Gupta NK, Nolan A, Omuro A et al (2017) Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro Oncol 19(1):99\u2013108","journal-title":"Neuro Oncol"},{"key":"3208_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/1471-2407-8-225","volume":"8","author":"IS Haldorsen","year":"2008","unstructured":"Haldorsen IS, Krakenes J, Goplen AK, Dunlop O, Mella O, Espeland A (2008) AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003. BMC Cancer 8:225","journal-title":"BMC Cancer"},{"issue":"25","key":"3208_CR25","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJM199012203232502","volume":"323","author":"LJ Swinnen","year":"1990","unstructured":"Swinnen LJ, Costanzo-Nordin MR, Fisher SG et al (1990) Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 323(25):1723\u20131728","journal-title":"N Engl J Med"},{"issue":"2","key":"3208_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00007890-198902000-00020","volume":"47","author":"AH Wilkinson","year":"1989","unstructured":"Wilkinson AH, Smith JL, Hunsicker LG et al (1989) Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 47(2):293\u2013296","journal-title":"Transplantation"},{"issue":"2","key":"3208_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","volume":"35","author":"AM de Mattos","year":"2000","unstructured":"de Mattos AM, Olyaei AJ, Bennett WM (2000) Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis 35(2):333\u2013346","journal-title":"Am J Kidney Dis"},{"issue":"32","key":"3208_CR28","doi-asserted-by":"publisher","first-page":"33849","DOI":"10.18632\/oncotarget.5292","volume":"6","author":"GM Crane","year":"2015","unstructured":"Crane GM, Powell H, Kostadinov R et al (2015) Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage. Oncotarget 6(32):33849\u201333866","journal-title":"Oncotarget"},{"issue":"8","key":"3208_CR29","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","volume":"98","author":"C Besson","year":"2001","unstructured":"Besson C, Goubar A, Gabarre J et al (2001) Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98(8):2339\u20132344","journal-title":"Blood"},{"issue":"1","key":"3208_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1148\/radiol.2241010637","volume":"224","author":"AC Guo","year":"2002","unstructured":"Guo AC, Cummings TJ, Dash RC et al (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224(1):177\u2013183","journal-title":"Radiology"},{"issue":"14","key":"3208_CR31","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1182\/blood-2011-08-373738","volume":"119","author":"K Dunleavy","year":"2012","unstructured":"Dunleavy K, Wilson WH (2012) How I treat HIV-associated lymphoma. Blood 119(14):3245\u20133255","journal-title":"Blood"},{"issue":"6","key":"3208_CR32","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","volume":"14","author":"E Salloum","year":"1996","unstructured":"Salloum E, Cooper DL, Howe G et al (1996) Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14(6):1943\u20131949","journal-title":"J Clin Oncol"},{"issue":"6","key":"3208_CR33","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","volume":"11","author":"BC Widemann","year":"2006","unstructured":"Widemann BC, Adamson PC (2006) Understanding and managing methotrexate nephrotoxicity. Oncologist 11(6):694\u2013703","journal-title":"Oncologist"},{"issue":"3","key":"3208_CR34","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1212\/WNL.58.3.390","volume":"58","author":"B Gleissner","year":"2002","unstructured":"Gleissner B, Siehl J, Korfel A, Reinhardt R, Thiel E (2002) CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes. Neurology 58(3):390\u2013396","journal-title":"Neurology"},{"issue":"6","key":"3208_CR35","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/sj.leu.2403376","volume":"18","author":"G Mitterbauer-Hohendanner","year":"2004","unstructured":"Mitterbauer-Hohendanner G, Mannhalter C, Winkler K et al (2004) Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL). Leukemia 18(6):1102\u20131107","journal-title":"Leukemia"},{"issue":"2","key":"3208_CR36","first-page":"81","volume":"4","author":"A Bagg","year":"2002","unstructured":"Bagg A, Braziel RM, Arber DA, Bijwaard KE, Chu AY (2002) Immunoglobulin heavy chain gene analysis in lymphomas: a multi-center study demonstrating the heterogeneity of performance of polymerase chain reaction assays. JMD 4(2):81\u201389","journal-title":"JMD"},{"issue":"2","key":"3208_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3171\/jns.1983.58.2.0159","volume":"58","author":"PC Burger","year":"1983","unstructured":"Burger PC, Dubois PJ, Schold SC et al (1983) Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58(2):159\u2013169","journal-title":"J Neurosurg"},{"issue":"1","key":"3208_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3174\/ajnr.A1750","volume":"31","author":"RF Barajas Jr","year":"2010","unstructured":"Barajas RF Jr, Rubenstein JL, Chang JS, Hwang J, Cha S (2010) Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR 31(1):60\u201366","journal-title":"AJNR"},{"issue":"8868","key":"3208_CR39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/0140-6736(93)92814-A","volume":"342","author":"P Cinque","year":"1993","unstructured":"Cinque P, Brytting M, Vago L et al (1993) Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 342(8868):398\u2013401","journal-title":"Lancet"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03208-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-019-03208-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03208-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T23:12:28Z","timestamp":1591917148000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-019-03208-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,13]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3208"],"URL":"https:\/\/doi.org\/10.1007\/s11060-019-03208-w","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,13]]},"assertion":[{"value":"10 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare that they have competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}